biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > End is Nearing Fast

<< Previous

Bullboard Posts

Next >>

Comment by chrispion May 29, 2022 1:38pm

190 Views

Post# 34715501

RE:RE:RE:RE:RE:RE:RE:RE:RE:End is Nearing Fast

MBT123 wrote: Maybe a first class ticket was all the "undisclosed" upfront payment she bargained to play with this apparently "useless" technology...Not even sure why she would show her face after years of all-time lows under her guidance..Maybe she is as arrogant as JD

MBT123, your math skills are on par with a 5 year old.
The 52 week low for BTI is .195 and the current share price is more than 25% higher than that.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec